FOSUN HEALTH Logo

Bladder Cancer Symptoms

catalogue

Bladder Cancer Symptoms

Bladder Cancer Symptoms

Bladder cancer is unusual in that its commonest early symptom is one a patient can see, and one that rarely hurts. That combination — visible and painless — is what brings people to a doctor, and it is also the reason it should not be attributed to something minor without looking. A second, quieter presentation exists: irritative urinary symptoms with no blood at all, which more often accompanies flat, high-grade disease.

Why blood is the signal

The bladder is a reservoir, and the urothelium lining it sits in contact with concentrated urine for hours at a time. A tumour growing from that lining is fragile: its surface vessels are irregular, they bleed intermittently, and the blood mixes with urine and is voided — which is why the sign of this cancer is something seen in the toilet rather than something felt in the body.

Three properties of that bleeding explain why it is treated as a finding rather than a complaint. It is usually painless, so it does not feel urgent. It is intermittent — the bleeding stops, sometimes for weeks, which is why it is so often explained away and why a clear interval means nothing. And it is not proportional to the size or seriousness of the tumour: a flat carcinoma in situ may produce very little visible blood, while a small benign lesion can produce a lot.

The consequence is the same in each direction. A single episode of visible blood in the urine in an adult is investigated, not monitored, and the investigation is cystoscopy together with imaging of the upper urinary tract — because the same continuous lining runs up to the kidneys.

Visible and microscopic blood

Blood in the urine is described by whether it can be seen, and the two forms are approached differently:

  • Visible haematuria — pink, red or, characteristically, the colour of weak tea or cola. Tea-coloured urine usually means older blood that has been in the bladder for a while rather than fresh bleeding, and it is not a milder finding.
  • Microscopic haematuria — detected only on urine testing, most often during an unrelated examination such as a general check-up, pre-employment screening or pre-operative work-up. It is a common finding with many causes, and its significance depends on age, smoking history, exposure history and whether it persists on repeat testing. Because it produces no symptoms, it is the easier finding to set aside.
  • Clots — indicate heavier bleeding and can obstruct the flow of urine, which is a reason for urgent rather than routine assessment.

Four practical points reduce confusion. First, a single episode of visible blood is enough to justify investigation: there is no need to wait for it to happen again, because a clear interval says neither that the lesion has gone nor that it is improving. Second, whether microscopic blood needs investigating depends on the level of risk — in a smoker, in someone with an occupational exposure or previous pelvic radiotherapy, or in someone who has had a urothelial tumour before, persistent microscopic blood is treated as seriously as a symptom, whereas in a young person with no exposure and an obvious explanation such as strenuous exercise or a sample taken during menstruation, repeating the test before deciding on further investigation is reasonable. Third, the visual appearance does not identify the source: stones, infection, kidney disease and prostate enlargement all produce blood that looks the same, so a benign diagnosis elsewhere in the urinary tract does not explain away an episode without cystoscopy. Fourth, anticoagulants and antiplatelet drugs are not a sufficient explanation — they make existing bleeding more visible rather than causing bleeding from a healthy urinary tract, and a patient on one of these drugs with visible haematuria still needs the urinary tract examined.

Whatever the type, blood is not something that is finished with once it has been passed. Haematuria itself does not damage the bladder; the question it raises is what may be on the lining that produced it.

Irritative symptoms

A significant minority of patients never see blood. Their symptoms are the ones usually attributed to infection — frequency, urgency, burning, and getting up at night — and this presentation matters because of which tumour it tends to accompany:

  • Frequency and urgency that persist or recur after antibiotics have been given.
  • Burning or discomfort on urination, without a positive urine culture or without responding to treatment.
  • Nocturia and a reduced bladder capacity, from a bladder that is irritated rather than infected.
  • Carcinoma in situ — a flat, high-grade lesion that produces irritative symptoms rather than bleeding and can be invisible on white-light cystoscopy.

The pattern to watch for is treatment that does not work. Urinary infection in adults is common and usually settles with antibiotics, and the commonest route to delay is the cycle that follows: treatment, improvement, recurrence, further treatment — until a urine test happens to show blood, or a cystoscopy happens to show something. The problem is not that antibiotics were used; it is that relief of symptoms does not exclude a tumour, because irritative symptoms caused by a tumour also come and go. This is how flat, high-grade disease is usually found — and it is worth finding, because it is the non-muscle-invasive form most likely to progress.

The situations that should move a patient from “recurrent infection” to urological assessment are therefore specific: irritative symptoms that keep recurring with negative urine cultures; a positive culture whose symptoms do not settle despite adequate treatment; symptoms that do not improve when post-menopausal genitourinary atrophy is treated; and a first episode of irritative symptoms lasting several weeks in a man over 45, or at any age in someone with a smoking history. The step at that point is cystoscopy, not another course of the same antibiotic.

Signs of advanced disease

When the tumour has grown beyond the bladder wall or spread, the signs become local and systemic at once:

  • Pelvic pain or a sensation of pressure, sometimes radiating to the perineum, back or thighs, from the tumour invading the structures around the bladder.
  • Flank pain from a tumour blocking the flow of urine from a kidney — it may begin as a dull ache, and it may be entirely painless.
  • Swelling of one or both legs when pelvic lymph nodes obstruct lymphatic drainage, often beginning on one side.
  • Bone pain, most often in the spine, pelvis or ribs, indicating spread to the skeleton; pain that persists, is worse at night and is not relieved by rest deserves particular attention.
  • Weight loss, fatigue and loss of appetite — non-specific in themselves, but meaningful when they occur alongside the other findings.
  • Inability to pass urine from a tumour at the bladder outlet, or clot retention from blood clots obstructing the urethra — an emergency requiring immediate attention regardless of cause.

Two points are worth stating plainly. Most of these findings are not specific to bladder cancer — the common cause of flank pain is a stone or a muscle problem — so there is no need to be alarmed, but the distinction should be made by a doctor rather than assumed. And these findings rarely appear together: any one of them is enough to justify prompt assessment, and if imaging already shows hydronephrosis, the time window is tighter. Because non-muscle-invasive disease is by far the commonest presentation and is usually caught through bleeding, these signs are the exception rather than the rule; they matter because they change the stage and therefore the treatment, and because a few of them are time-critical.

Why the kidneys are examined too

Urothelial carcinoma does not respect the boundary between organs. Because the lining runs continuously from the renal pelvis through the ureter, into the bladder and out along the urethra, a tumour found in the bladder raises the question of whether there is a second one above it. Examining the upper tract is therefore not an extra test but part of staging and treatment planning.

The reason is twofold. First, about 2–5% of patients with bladder cancer have a synchronous or later upper-tract tumour, and a proportion of those would be missed entirely if only the bladder were inspected. Second, a finding in the upper tract changes the sequence of treatment: if the kidney or ureter is also involved, the plan has to cover both sites rather than dealing with the bladder first. None of this means the first tumour was treated inadequately — it is a property of the tissue, not of the treatment.

The examination is normally CT urography, which images the whole urinary tract in the excretory phase and assesses kidney function and obstruction at the same time; where contrast is unsafe because of allergy or kidney function, MR urography or ultrasound with retrograde studies can be used instead. Because patients are followed for years, upper-tract imaging is not a one-off: it is built into the follow-up schedule at intervals. The practical instruction for a patient is specific — CT urography done at the time of diagnosis should be brought to any second-opinion consultation, and a history of bladder cancer should be mentioned when kidney symptoms are assessed later, so that the upper tract is examined rather than assumed to be normal.

When to see a doctor

The findings below call for urological assessment — urine testing and, where indicated, cystoscopy and imaging:

  • Blood in the urine that the patient can see — at any age, whatever its apparent cause, and even if it has already stopped; a single episode is enough to justify cystoscopy
  • Blood found on urine testing that persists on repeat examination, particularly over 45, in a smoker, or in someone with an occupational exposure, a previous urothelial tumour or previous pelvic radiotherapy
  • Irritative urinary symptoms that persist after antibiotics, or recur with negative cultures — particularly over 45 or with a smoking history
  • Visible blood in the urine while taking an anticoagulant or an antiplatelet drug
  • Inability to pass urine, or bleeding with clots — same-day attention rather than the next available appointment
  • A history of occupational exposure to dyes, rubber, leather, paint, printing, aluminium or hairdressing, or previous pelvic radiotherapy, with any urinary symptom
  • Flank pain, bone pain or swelling of the legs — prompt assessment, and a tighter time window if imaging already shows hydronephrosis

Two closing points on what this list does not say. Most people with visible haematuria do not have cancer, and the purpose of investigating it is not to alarm anyone but to replace waiting with a defined next step. And the absence of every finding on the list is not reassurance for a patient with a substantial smoking or occupational history, because this cancer can be present without bleeding at all — the question for that patient is not whether to act on a symptom, but when to discuss the purpose and limits of urinary testing, which is the subject of the prevention page.

One thing is worth doing proactively at the consultation: give your full smoking history and occupational history, including any industries you have left. Bladder cancer usually takes decades from exposure to diagnosis, so work in dye, rubber, leather, paint, printing or aluminium thirty years ago is still relevant — and this is information only the patient can provide. It does not change whether you need to be examined, but it changes how urgently the doctor will judge that assessment.

Frequently Asked Questions

I saw blood in my urine once and it stopped. Do I still need to be checked?

Yes. Intermittent bleeding is characteristic of bladder cancer rather than an argument against it, and an interval of clear urine says nothing about whether a tumour is present. Most episodes of visible haematuria turn out to have a benign cause — infection, a stone, kidney disease, strenuous exercise or an enlarged prostate — but the only way to establish that is to look: urine testing, cystoscopy and imaging of the upper urinary tract. Waiting for the bleeding to return is the delay this page is written to prevent.

Could this be a urinary infection instead?

Often it is, and infection is far commoner than cancer. The features that shift the balance towards infection are pain on urination, fever and a rapid onset with a positive urine culture; features that do not are painless visible bleeding, or irritative symptoms that persist after antibiotics or recur with negative cultures. Because the two can coexist, a treated infection does not exclude a tumour, and persistent symptoms after treatment are the point at which assessment should move from another antibiotic to cystoscopy.

Do blood thinners cause the bleeding?

They make bleeding more visible and more prolonged, but they do not by themselves cause bleeding from a healthy urinary tract. That distinction matters clinically: in a patient taking an anticoagulant or antiplatelet drug, it is common to attribute haematuria to the medication and stop investigating — which delays the diagnosis of whatever is bleeding. The standard approach is to examine the urinary tract rather than assume the drug explains it.

Is there a test I can do at home that would find this early?

There are dipstick tests for blood in the urine, but they are not a reliable early-detection tool, and using them that way produces a large number of false alarms and further tests without established benefit. What they are useful for is confirming what has been noticed: if you have seen blood in the urine and a dipstick confirms it, that is a reason to arrange assessment. Population screening for bladder cancer is not recommended, which is why attention to symptoms and to your own risk profile matters more than testing without a reason.

Blood in the urine seen once is still worth investigating

Send us the urine test result, the cytology result, the cystoscopy report if one has been done, and the CT urography. Our urological oncology team will return a written assessment within 48 hours of the file being complete, including which risk category the findings point to and what the next step should be.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*